Optical & dispensary
The margin in the optical floor, frame and lens mix, and managed-vision contracts. Most advisors do not know how to value it. I do.
For ophthalmology & optometry practice owners
Most M&A advisors have never set foot in a surgical suite or an exam lane. I have spent my career in both. If you are thinking about selling your ophthalmology or optometry practice, you should work with someone who understands premium IOL conversion, buy-and-bill, ASC economics, and the way private equity and DSOs actually value what you built.
Every conversation is confidential. No pressure, no obligation.
Why me
I built a twelve-year career inside ophthalmology. I carried the bag for Bausch + Lomb selling phacoemulsification and vitrectomy systems to surgeons across anterior and posterior segment. I sold ophthalmic lasers for Lumenis. I ran the U.S. sales organization as National Director of Sales for a cataract technology company, and I have worked the retina buy-and-bill side with branded therapies. I have trained residents and fellows, sat in on cases, and helped surgery centers raise profit per procedure.
It started long before that. My mom and my aunt ran a single-doctor optometry practice for my entire childhood, so I grew up around the front desk, the optical floor, the insurance headaches, and the reality of what it takes to keep a practice profitable. From the optometry clinic I grew up in to the surgical suites I have worked in ever since, I know eye care from end to end. I understand the doctors, the buyers, the vendors, and the economics, because I have lived in this industry, not read about it.
A generalist broker will list your practice and miss the things that actually move your price. Eye care has its own economics, and a buyer prices every one of them:
The margin in the optical floor, frame and lens mix, and managed-vision contracts. Most advisors do not know how to value it. I do.
Premium IOL conversion, case mix, and ownership in an ambulatory surgery center. Profit per procedure is where real value hides.
How your revenue is built, reimbursement exposure, and the durability of the payer base a buyer is underwriting.
How much of the practice walks out the door if you do. For a single-doctor practice, this is the number-one driver of the deal terms.
Eye care is consolidating fast. The buyers are not a mystery to me: DSOs and MSOs building regional platforms, private equity groups rolling up ophthalmology and optometry, larger MD and OD groups expanding by acquisition, and individual doctors buying in. Each one values your practice on a different basis and structures a deal differently. The mistake owners make is taking the first call from the first acquirer. My job is to put the right buyers in competition for your practice so you negotiate from strength, with the terms, the cash at closing, and the post-sale role that actually work for you.
One advisor who understands your world, with two firms behind the deal.
First we get the practice ready: clean, defensible financials and a clear picture of the optical, surgical, and payer economics, handled through Thryve Accounting & Advisory, ideally a year or two before you go to market. Then we position the practice, build a targeted list of the buyers who would pay a premium for it, and run a disciplined process that creates real competition. The transaction itself is executed through Optima Mergers & Acquisitions, a Dallas middle-market investment bank named to Axial's Advisor 100. You get senior, eye-care-fluent attention and institutional muscle on the same deal.
Questions owners ask
Most active buyers fall into a few groups: DSOs and MSOs, private equity platforms rolling up eye care, larger ophthalmology and optometry groups expanding by acquisition, and individual MDs or ODs buying in. Each values a practice differently, and knowing which buyer fits yours is how you create competition instead of taking the first offer.
Eye care has its own economics: payer mix and buy-and-bill, optical and dispensary revenue, premium IOL conversion, ASC ownership and profit per procedure, equipment, and the doctor's role in production. A generalist broker misses these. They are exactly the levers that move your multiple, and they need to be understood and documented before a buyer sees them.
Ideally one to two years out. Reducing how much the practice depends on you personally, cleaning up the financials, and documenting the optical, surgical, and payer economics all take time, and they are what lift the price. Start early and you go to market with leverage instead of taking what the first buyer offers.
My home base is Texas, but eye care is a national market and so are its buyers. I work with ophthalmology and optometry practice owners across the country. The first conversation is the same wherever you are.